The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes
Abstract There is growing focus on mitochondrial impairment and cardiovascular diseases (CVD) in type 2 diabetes (T2D), and the development of novel therapeutic strategies in this context. It is unknown whether mitochondrial-targeting antioxidants such as SS-31 protect sufficiently against oxidative...
Main Authors: | Irene Escribano-Lopez, Noelia Diaz-Morales, Francesca Iannantuoni, Sandra Lopez-Domenech, Aranzazu M de Marañon, Zaida Abad-Jimenez, Celia Bañuls, Susana Rovira-Llopis, Jose R Herance, Milagros Rocha, Victor M Victor |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-10-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-018-34251-8 |
Similar Items
-
SIRT7 and hepatic lipid metabolism
by: Bor Luen eTang
Published: (2015-01-01) -
Combined Inhibition of Specific Sirtuins as a Potential Strategy to Inhibit Melanoma Growth
by: Chandra K. Singh, et al.
Published: (2020-10-01) -
The expression of Sirtuins 1 and 4 in peripheral blood leukocytes from patients with type 2 diabetes
by: R. Song, et al.
Published: (2011-03-01) -
Mammalian Sirt1: insights on its biological functions
by: Islam Rezuanul, et al.
Published: (2011-05-01) -
The Role of Sirt1 in Ischemic Stroke: Pathogenesis and Therapeutic Strategies
by: Jun-Fang Zhang, et al.
Published: (2018-11-01)